UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000061512
Receipt number R000070387
Scientific Title Development and Efficacy Assessment of an Oral Health Education Program for Older Adults with Depressive Symptoms in Myanmar
Date of disclosure of the study information 2026/05/10
Last modified on 2026/05/10 19:18:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development and Efficacy Assessment of an Oral Health Education Program for Older Adults with Depressive Symptoms in Myanmar

Acronym

Development and Efficacy Assessment of an Oral Health Education Program for Older Adults with Depressive Symptoms in Myanmar

Scientific Title

Development and Efficacy Assessment of an Oral Health Education Program for Older Adults with Depressive Symptoms in Myanmar

Scientific Title:Acronym

Development and Efficacy Assessment of an Oral Health Education Program for Older Adults with Depressive Symptoms in Myanmar

Region

Asia(except Japan)


Condition

Condition

Depressive symptoms and oral disease in older adults

Classification by specialty

Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effectiveness of a community-based oral health education program on oral health status in community-dwelling older adults aged 60 years and above, with and without depressive symptoms, in Yangon, Myanmar, over an 18-month follow-up period.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Modified Plaque Index

Key secondary outcomes

DMFT index; pocket depth; bleeding on probing; resting and stimulated salivary flow rate; oral bacterial count; Oral Health Impact Profile-14 (OHIP-14); DASS-21 (depression, anxiety, stress); Activities of Daily Living (ADL); Instrumental ADL (IADL); Geriatric Depression Scale-15 (GDS-15)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

Those with depressive symptoms (Group 1): Oral health education program consisting of: (1) in-person slide-show presentations delivered in groups of 10 participants at 3-month intervals; (2) weekly reminder SMS messages; (3) an illustrated oral health education booklet.
Total duration: 18 months.

Interventions/Control_2

Those with depressive symptoms (Group 2): Control.
No oral health education intervention.

Interventions/Control_3

Those without depressive symptoms (Group 3): Oral health education program consisting of: (1) in-person slide-show presentations delivered in groups of 10 participants at 3-month intervals; (2) weekly reminder SMS messages; (3) an illustrated oral health education booklet.
Total duration: 18 months.

Interventions/Control_4

Those without depressive symptoms (Group 2): Control.
No oral health education intervention.

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Community-dwelling older adults aged 60 years and above attending a township health centre in Yangon, Myanmar; able to provide informed consent

Key exclusion criteria

Cognitive impairment (MMSE score below threshold); severe systemic illness preventing participation; inability to attend follow-up; edentulous individuals; Unable to participate mentally and/or physically; Recent dental treatment < 6 months; Taking antidepressants or medicines that affect the saliva production

Target sample size

240


Research contact person

Name of lead principal investigator

1st name Kaung Myat
Middle name
Last name Thwin

Organization

Niigata University, Graduate School of Medicine, Dentistry and Health Sciences, Faculty of Dentistry

Division name

Division of Preventive Dentistry

Zip code

951-8514

Address

2-5274, Gakkocho-dori, Chuo-ku, Niigata-shi, Niigata, Japan

TEL

0252272858

Email

kaung@dent.niigata-u.ac.jp


Public contact

Name of contact person

1st name Kaung Myat
Middle name
Last name Thwin

Organization

Niigata University, Graduate School of Medicine, Dentistry and Health Sciences, Faculty of Dentistry

Division name

Division of Preventive Dentistry

Zip code

9518514

Address

2-5274, Gakkocho-dori, Chuo-ku, Niigata-shi, Niigata, Japan

TEL

817021745789

Homepage URL


Email

kaung@dent.niigata-u.ac.jp


Sponsor or person

Institute

Niigata University, Graduate School of Medicine, Dentistry and Health Sciences, Faculty of Dentistry
Division of Preventive Dentistry

Institute

Department

Personal name

Kaung Myat Thwin


Funding Source

Organization

Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid for Early-Career Scientists, Grant Number 24K20102

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Niigata University


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Niigata University

Address

2-5274, Gakkocho-dori, Chuo-ku, Niigata-shi, Niigata, Japan

Tel

+81252272858

Email

kaung@dent.niigata-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 05 Month 10 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

245

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 05 Month 01 Day

Date of IRB

2023 Year 01 Month 27 Day

Anticipated trial start date

2024 Year 08 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 05 Month 10 Day

Last modified on

2026 Year 05 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070387